Traynor Capital Management, Inc. T2 Biosystems, Inc. Transaction History

Traynor Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$0.09 - $565.0 $4,995 - $31.4 Million	55,500 New	55,500 $6,000
Q2 2022 Jul 28, 2022	BUY	$0.15 - $0.54 $1,500 - $5,401	10,002 Added 48.79%	30,502 $4,000
Q4 2021 Feb 01, 2022	BUY	$0.46 - $0.94 $460 - $940	1,000 Added 5.13%	20,500 $10,000
Q3 2021 Oct 25, 2021	BUY	$0.86 - $1.21 $3,440 - $4,840	4,000 Added 25.81%	19,500 $17,000
Q2 2021 Jul 21, 2021	SELL	$1.04 - $1.69 $1,040 - $1,690	-1,000 Reduced 6.06%	15,500 $17,000
Q1 2021 May 04, 2021	BUY	$1.32 - $3.79 $21,780 - $62,535	16,500 New	16,500 $26,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.